Fremanezumab in the treatment of migraines: evidence to date

por Robblee, Jennifer, VanderPluym, Juliana
Publicado 2019

Profile of Lasmiditan in the Acute Treatment of Migraine in Adults: Design, Development, and Place in Therapy

por Anderson, Christopher C, VanderPluym, Juliana H
Publicado 2023

Ubrogepant in the Acute Management of Migraine: A Narrative Review

por Chiang, Chia-Chun, VanderPluym, Juliana H
Publicado 2021

Genomic characterization of chromosome 8 pericentric trisomy

por Vander Pluym, Juliana H, O’Sullivan, Julia, Andrew, Gail, Bolduc, Francois V
Publicado 2015

Fremanezumab for preventive treatment of migraine: Functional status on headache-free days

por VanderPluym, Juliana, Dodick, David W., Lipton, Richard B., Ma, Yuju, Loupe, Pippa S., Bigal, Marcelo E.
Publicado 2018

Evaluation of the Safety of Calcitonin Gene-Related Peptide Antagonists for Migraine Treatment Among Adults With Raynaud Phenomenon

por Breen, Ilana D., Brumfiel, Caitlin M., Patel, Meera H., Butterfield, Richard J., VanderPluym, Juliana H., Griffing, Leroy, Pittelkow, Mark R., Mangold, Aaron R.
Publicado 2021

TEV-48125 for the preventive treatment of chronic migraine: Efficacy at early time points

por Bigal, Marcelo E., Dodick, David W., Krymchantowski, Abouch V., VanderPluym, Juliana H., Tepper, Stewart J., Aycardi, Ernesto, Loupe, Pippa S., Ma, Yuju, Goadsby, Peter J.
Publicado 2016